NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OncoTag

OncoTag

Private
Nova LimaHealthcare & Life Scienceshttps://oncotag.com.br/

Last Round

Grant

Oct 19, 2023

Total Funding Raised

$75,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OncoTag is a biotechnology company that operates a genetic analysis laboratory focused on precision oncology by developing molecular tests to assist in the treatment of cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsprecision medicineNGSnext-generation sequencingoncology diagnosticsgenetic testingcancer genomicspersonalized cancer treatmentai-driven diagnosticsbioinformaticsqRT-PCRclinical decision supportmedtechhealthtechai in healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoTag Comparables

Compare OncoTag with similar companies based on industry and business-model similarity.

OncoTag comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Onkos Diagnósticos Moleculares
79%
OncoDNA
77%
Mendelics Análise Genômica
76%

OncoTag Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 19, 2023
SeedAug 8, 2023
AcceleratorOct 15, 2018

Key People

Founding team and executive leadership

Leticia Braga

Chief Executive Officer

Executive Team

MSc Pedro Villar

Pesquisador Imunologista Pesquisa Translacional Em Oncologia CEO, CEO - Chief Executive Officer, CEO

Executive Team

OncoTag Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 36% MoM.

  • May 3, 2026

    Grew 50% QoQ from 6 to 9 employees.

OncoTag Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoTag Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoTag's valuation, stock price, and market status.

Firmographic Details

HeadquartersNova Lima
Employee Range9
Year Founded2014
Last FundingOct 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.